🇺🇸 FDA
Patent

US 9550078

EDAR ligand derived peptides and use thereof

granted A61KA61K38/00A61K8/64

Quick answer

US patent 9550078 (EDAR ligand derived peptides and use thereof) held by CAREGEN CO., LTD. expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61K8/64, A61P, A61P17/00